Characterization and HIV-1 Fusion Inhibitory Properties of Monoclonal Fabs Obtained From a Human Non-immune Phage Library Selected Against Diverse Epitopes of the Ectodomain of HIV-1 gp41
- 30 September 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 353 (5), 945-951
- https://doi.org/10.1016/j.jmb.2005.09.044
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 32 references indexed in Scilit:
- Differential Inhibition of HIV-1 and SIV Envelope-Mediated Cell Fusion by C34 Peptides Derived from the C-Terminal Heptad Repeat of gp41 from Diverse Strains of HIV-1, HIV-2, and SIVJournal of Medicinal Chemistry, 2005
- The Prefusogenic Intermediate of HIV-1 gp41 Contains Exposed C-peptide RegionsJournal of Biological Chemistry, 2003
- Mechanisms of Viral Membrane Fusion and Its InhibitionAnnual Review of Biochemistry, 2001
- Protein Design of an HIV-1 Entry InhibitorScience, 2001
- Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug targetProceedings of the National Academy of Sciences, 1998
- HIV Entry and Its InhibitionCell, 1998
- Capture of an early fusion-active conformation of HIV-1 gp41Nature Structural & Molecular Biology, 1998
- Co-receptors for HIV-1 entryCurrent Opinion in Immunology, 1997
- The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus InfectionJournal of Biological Chemistry, 1995
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences, 1994